Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2026-01-29 00:00:00 ET · period of report 2026-01-29 · accession 0001193125-26-029895 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-29 | 2026-01-29 | SRPT | Nicaise Claude | Dir | F - Tax | $21.23 | -6,780 | 31.5K | -18% | -$143.9K |
| D | 2026-01-29 | 2026-01-29 | SRPT | Nicaise Claude | Dir | M - OptEx | $13.71 | +10.5K | 38.3K | +38% | +$144.0K |
| D | 2026-01-29 | 2026-01-29 | SRPT | Nicaise Claude | Dir | M - OptEx | $0.00 | -10.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-29 | F | D | 6,780 | $21.23 | 31,532 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-29 | M | A | 10,500 | $13.71 | 38,312 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-01-29 | M | D | 10,500 | $0.00 | 0 | D | $13.71 · 2017-02-28 to 2026-02-28 | 10,500 Common Stock |